Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.
about
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewHigh CRP values predict poor survival in patients with penile cancer.Elevated C-reactive protein values predict nodal metastasis in patients with penile cancerPrognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy.The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patientsBreast cancer as a systemic disease: a view of metastasisImmunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor.Plasma osteopontin concentrations in patients with cutaneous melanomaDNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening.Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer.The proteomic landscape of renal tumors.Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma
P2860
Q26771557-8239BFAC-AAA2-4E44-B70D-BA2B77E69546Q34705218-F5C945D8-9AF5-4DDF-81A6-7B70EF82AC32Q35024082-51C61BDB-1A4C-4222-A3DD-FCF86E9DEF5EQ35451764-55E9637F-15EA-4027-8E40-B213C68542EEQ35963306-5BB2B92E-26C1-438B-92B9-E468627DC07FQ36298727-458EE232-6945-4D85-A97E-6F0B877C8E2FQ37011741-449C5614-F44B-4ADD-8125-9281D52C1830Q37134694-D86622F1-C337-460D-A5BB-E0440A1646B3Q37260595-68C0D769-9BAC-4399-A793-E0B718FF426AQ37649509-29708265-42AF-4D2C-89CD-E9D1814C5805Q38294622-AFF21858-5567-41A2-BCD7-460C00D7B60AQ38803559-B410E2A1-4DF4-4E05-A421-1DB7FF68B27CQ38861806-EB27A57F-5E5E-4237-AF08-AE94936218F6Q40264726-DE03D3CF-072B-40C7-BD36-96A2FBD7E184Q46773554-55BDC00E-EB02-4845-A197-05A22FABC613Q52687755-6C89B7F6-6DF7-4610-9259-91105A4AA04CQ58578839-5D56474F-A5F8-4CB4-9D97-E6FF1E6F02FA
P2860
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prognostic utility of pre-oper ...... d CRP in renal cell carcinoma.
@ast
Prognostic utility of pre-oper ...... d CRP in renal cell carcinoma.
@en
type
label
Prognostic utility of pre-oper ...... d CRP in renal cell carcinoma.
@ast
Prognostic utility of pre-oper ...... d CRP in renal cell carcinoma.
@en
prefLabel
Prognostic utility of pre-oper ...... d CRP in renal cell carcinoma.
@ast
Prognostic utility of pre-oper ...... d CRP in renal cell carcinoma.
@en
P2093
P2860
P356
P1476
Prognostic utility of pre-oper ...... nd CRP in renal cell carcinoma
@en
P2093
D Thompson
J Cartledge
N S Vasudev
W M Gregory
P2860
P2888
P304
P356
10.1038/BJC.2012.360
P407
P577
2012-08-23T00:00:00Z